- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.05. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026 | 291 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting... ► Artikel lesen | |
| 22.05. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026 | 441 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026... ► Artikel lesen | |
| NEUROONE MEDICAL TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 22.05. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 18.05. | Trotz verfehlter Q2-Prognosen: NeuroOne-Aktie im Aufwind | 3 | Investing.com Deutsch | ||
| 12.05. | NeuroOne Medical Tech Q2 2026 Earnings Call Transcript | 1 | Benzinga.com | ||
| 12.05. | NeuroOne Medical Technologies GAAP EPS of -$0.25 misses by $0.02, revenue of $2.4M misses by $0.18M | 1 | Seeking Alpha | ||
| 12.05. | NeuroOne outlines ISO 13485 certification in latter part of 2026 while targeting drug delivery availability in second half of fiscal 2026 | 2 | Seeking Alpha | ||
| 12.05. | NeuroOne verfehlt Q2-Prognosen: Aktie gibt nach | 1 | Investing.com Deutsch | ||
| 12.05. | EQS-News: NeuroOne Medical Technologies: NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update | 1.197 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update 12.05.2026 / 14:03 CET/CEST
The... ► Artikel lesen | |
| 12.05. | NEUROONE MEDICAL TECHNOLOGIES Corp - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 12.05. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 04.05. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Regains Compliance With Nasdaq Listing Requirement | 270 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Regains Compliance With Nasdaq Listing Requirement 04.05.2026 / 14:34 CET/CEST
The issuer is solely... ► Artikel lesen | |
| 30.04. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Announces Chief Financial Officer Succession Plan | 439 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Announces Chief Financial Officer Succession Plan 30.04.2026 / 14:32 CET/CEST
The issuer is solely... ► Artikel lesen | |
| 30.04. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 28.04. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) to Report Second Quarter Fiscal Year 2026 Financial Results on Tuesday, May 12 at 8:30 a.m. Eastern Time | 319 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) to Report Second Quarter Fiscal Year 2026 Financial Results on Tuesday, May 12 at 8:30 a.m. Eastern... ► Artikel lesen | |
| 15.04. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Advances Brain Drug Delivery Platform Through Collaboration With University of Minnesota | 402 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Tech
NeuroOne(R) Advances Brain Drug Delivery Platform Through Collaboration With University of Minnesota 15.04.2026 / 14:33... ► Artikel lesen | |
| 14.04. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance | 424 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance 14.04.2026 / 14:35... ► Artikel lesen | |
| 14.04. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 03.04. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | - | SEC Filings | ||
| 02.04. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Medical Technologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 466 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Medical Technologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 02.04.2026 / 23:23... ► Artikel lesen |
1 2 3 Weiter >>
41 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 37,260 | +1,61 % | DAX-Verlierer: Die fünf Verlierer des Monats im DAX - Diese Werte enttäuschten | © Foto: Julian Stratenschulte/dpa Der Mai 2026 brachte für Anleger Höhenflüge und Abstürze. Ein Überblick über die fünf schwächsten Aktien im DAX.Während einige DAX-Werte im Mai deutliche Kursgewinne... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 57,37 | -0,05 % | Fast-paced Momentum Stock BrightSpring Health Services, Inc. (BTSG) Is Still Trading at a Bargain | ||
| SIEMENS HEALTHINEERS | 34,840 | +0,55 % | Mentice AB: Mentice and Siemens Healthineers Announce Co-Marketing Partnership to Advance Neurovascular Treatment Planning | Gothenburg, Sweden - June 2026 - Mentice AB, a global leader in simulation and clinical decision support solutions for Image-Guided Therapies, today announced a co-marketing agreement with Siemens Healthineers... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,180 | +1,17 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 15,380 | +2,06 % | Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year | ||
| GENEDX | 52,26 | -7,13 % | Sema4.ai's autonomous agent building platform gets simpler to use, adds deeper business context and more | ||
| BILLIONTOONE | 97,20 | -7,07 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| PROGYNY | 25,850 | +1,49 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| ONCOLOGY INSTITUTE | 4,870 | +2,74 % | Oncology Institute, Inc. - 8-K, Current Report | ||
| CARL ZEISS MEDITEC | 26,740 | +0,38 % | Aktien - Shortseller-Positionen: Carl Zeiss Meditec, Evotec, HelloFresh, Kontron, LPKF Laser, TeamViewer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| VIVOS THERAPEUTICS | 0,856 | +23,54 % | Vivos Therapeutics, Inc: Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing | LITTLETON, Colo., June 05, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 27,850 | +3,19 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| UNITEDHEALTH | 346,20 | +1,35 % | Aktien New York Ausblick: Techwerte unter Druck nach KI-Ausblick von Broadcom | NEW YORK (dpa-AFX) - Ein enttäuschender Ausblick des Chipkonzerns Broadcom dürfte am Donnerstag für Moll-Stimmung an der Technologiebörse Nasdaq sorgen. Der Broker IG taxierte den viel beachteten Branchenindex... ► Artikel lesen | |
| ALPHA TAU MEDICAL | 9,360 | -8,99 % | Alpha Tau Medical Ltd.: Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting | - Results reinforce the potential feasibility and safety of Alpha DaRT as a one-time, minimally invasive intratumoral treatment that fits naturally into the patient journey - - Pooled analysis of... ► Artikel lesen | |
| HEARTFLOW | 28,110 | -2,43 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen |
NEUROONE MEDICAL TECHNOLOGIES CORPORATION gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -1,15 % bei einem Aktienkurs von 3,440 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEUROONE MEDICAL TECHNOLOGIES CORPORATION finden Sie auf Wallstreet Online.